Literature DB >> 16186414

Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity.

Christopher G Bell1, David Meyre, Chantal Samson, Cliona Boyle, Cécile Lecoeur, Maïte Tauber, Béatrice Jouret, Delphine Jaquet, Claire Levy-Marchal, Marie Aline Charles, Jacques Weill, Fernando Gibson, Charles A Mein, Philippe Froguel, Andrew J Walley.   

Abstract

Murine models have been highly effective in identifying the monogenic forms of human obesity discovered to date. Melanin-concentrating hormone receptor 1 (MCHR1) has been shown to be significant in the downstream orexigenic activity of the leptin-melanocortin pathway by such models. In this study, the human MCHR1 gene was extensively characterized by sequencing 3.5 kb of coding, untranslated and intronic regions plus 1 kb of putative promoter region in 180 morbidly obese adults and 87 morbidly obese children, a total of >2.4 Mb of sequencing. Thirty-nine single nucleotide polymorphisms (SNPs) were found, seven of which encode an amino acid change. One mutation, R248Q, appeared to cosegregate with the obesity trait in one pedigree but was also found to be a rare polymorphism in control samples. To investigate the possible polygenic role of MCHR1, the six common SNPs (minor allele frequency >5%) found in the sequenced regions were then screened in 557 morbidly obese adults, 552 obese children, and 1,195 nonobese nondiabetic control subjects. The plausible promoter SNP, rs133068, was found to be associated with protection against obesity in obese children only (allele frequency P = 0.006 and genotype frequency P = 0.004). Most significant results were found when using a dominant model (P = 0.001, odds ratio 0.695 [95% CI 0.560-0.863]). However, similar associations were found when both adults and children were analyzed together (P = 0.006, 0.783 [0.658-0.930]), suggesting that severe forms of obesity with early onset may be associated with SNPs in MCHR1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186414     DOI: 10.2337/diabetes.54.10.3049

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Peptide-cleaving catalyst selective for melanin-concentrating hormone: Oxidative decarboxylation of N-terminal aspartate catalyzed by Co(III)cyclen.

Authors:  Min Gyum Kim; Myoung-soon Kim; Seong Du Lee; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2006-07-13       Impact factor: 3.358

2.  Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects.

Authors:  A Siddiq; M Gueorguiev; C Samson; S Hercberg; B Heude; C Levy-Marchal; B Jouret; J Weill; D Meyre; A Walley; P Froguel
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

3.  Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.

Authors:  Rohit Loomba; Shih-Jen Hwang; Christopher J O'Donnell; R Curtis Ellison; Ramachandran S Vasan; Ralph B D'Agostino; T Jake Liang; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

4.  Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.

Authors:  E K Larkin; S R Patel; R C Elston; C Gray-McGuire; X Zhu; S Redline
Journal:  Ann Hum Genet       Date:  2008-08-26       Impact factor: 1.670

5.  The role of melanin-concentrating hormone and its receptors in energy homeostasis.

Authors:  Douglas J Macneil
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-22       Impact factor: 5.555

6.  Allele-specific, age-dependent and BMI-associated DNA methylation of human MCHR1.

Authors:  Stefanie Stepanow; Kathrin Reichwald; Klaus Huse; Ulrike Gausmann; Almut Nebel; Philip Rosenstiel; Martin Wabitsch; Pamela Fischer-Posovszky; Matthias Platzer
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

7.  Whole exome sequencing of extreme morbid obesity patients: translational implications for obesity and related disorders.

Authors:  Gilberto Paz-Filho; Margaret C S Boguszewski; Claudio A Mastronardi; Hardip R Patel; Angad S Johar; Aaron Chuah; Gavin A Huttley; Cesar L Boguszewski; Ma-Li Wong; Mauricio Arcos-Burgos; Julio Licinio
Journal:  Genes (Basel)       Date:  2014-08-25       Impact factor: 4.096

Review 8.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.